机译:前药4-氯-3-(5-甲基-3-{[4-(2-吡咯烷-1-基乙氧基)苯基]氨基} 1,2,4-苯并三嗪-7-基)苯甲酸苯基酯的研制(TG100801) :在临床试验中局部治疗的治疗性候选人,用于治疗与年龄有关的黄斑变性
ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; INHIBITS OCULAR NEOVASCULARIZATION; VEGF-INDUCED ANGIOGENESIS; CHOROIDAL NEOVASCULARIZATION; SUBRETINAL NEOVASCULARIZATION; IN-VIVO; SRC; PHOSPHORYLATION; TYROSINE-861;
机译:前药4-氯-3-(5-甲基-3-{[4-(2-吡咯烷-1-基乙氧基)苯基]氨基} 1,2,4-苯并三嗪-7-基)苯甲酸苯基酯的研制(TG100801) :在临床试验中局部治疗的治疗性候选人,用于治疗与年龄有关的黄斑变性
机译:干燥年龄相关性黄斑变性的治疗:治疗途径,临床试验和未来方向